Trial Profile
Pharmacokinetic study of KW-6485P for pediatric patients
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Feb 2020
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Kyowa Hakko Kirin; Kyowa Kirin
- 25 May 2016 New trial record